Maersk Container Industry’s Star Cool Integrated reefers to join ZIM Integrated Shipping Services’ fleet

Maersk Container Industry’s Star Cool Integrated reefers to join ZIM Integrated Shipping Services’ fleet

TINGLEV, Denmark, 28-May-2019 — /EuropaWire/ — Maersk Container Industry secures an order of 500 Star Cool Integrated Reefers from ZIM Integrated Shipping Services, establishing a strong relationship with the customer.

For decades, ZIM has been offering advanced transport of fruit, meat, medicines, and other frozen or refrigerated cargo to its customers. The company has developed unique technologies to ensure that reefer container transportation is as secure, reliable, and efficient as possible. ZIM’s innovative ZIMonitor system combines the latest technology with a comprehensive 24/7 response team.

“We are expanding our fleet of ZIMonitor containers to accommodate our customers’ growing demand for our exclusive ZIMonitor service, and we are sure MCI’s highly advanced and energy-efficient Star Cool Integrated reefers will be a great addition to our equipment fleet,” commented Dan Bartal, Container Fleet Manager at ZIM Integrated Shipping.

MCI’s Star Cool technology has a strong track record. It has around 300,000 units in operation across more than 40 container lines, leasing companies and multinational fruit companies around the globe. There is an increase in demand for the technology not only for its proven performance and reliability but to also help meet their growing sustainability objectives.

“Our Star Cool technology offers operators like ZIM the lowest total cost of ownership by combining reliability with lower operating costs, such as the most energy efficient reefer in the industry. We are pleased to see our product offering matching ZIM’s environmental ambitions so well,” adds Anders Holm, Global Head of Sales and Marketing at MCI.

Media contact:

Christian Kjaergaard-Winther (Senior Press Officer)
+45 3363 1786
E-mail Christian Kjaergaard-Winther

SOURCE: A.P. Moller – Maersk

MORE ON MAERSK, ETC.:

EDITOR'S PICK:

Comments are closed.